# Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)

> **NCT04795856** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Mitral Valve Regurgitation

## Interventions

- **DRUG:** [11C] acetate

## Key facts

- **NCT ID:** NCT04795856
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2027-06
- **Primary completion:** 2028-08
- **Final completion:** 2028-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of recruitment and PI departure
- **Last updated:** 2025-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04795856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04795856, "Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04795856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*